Disclosures for "Augmented Reality-based Physical Assessment (ARPA) for Remote Assessment of Patients with Prior Stroke: A Feasibility Study"
-
Dr. Espindola Lima has nothing to disclose.
-
Dr. Cho has nothing to disclose.
-
Ms. Muccini has nothing to disclose.
-
Mr. Kim has nothing to disclose.
-
Mr. Anaya Gallegos has nothing to disclose.
-
Mr. Sturgis has nothing to disclose.
-
Mr. Hu has nothing to disclose.
-
Miss Zhang has nothing to disclose.
-
-
Mr. Perlich has nothing to disclose.
-
Dr. Rengarajan has nothing to disclose.
-
The institution of Prof. Seshia has received research support from National Science Foundation. The institution of Prof. Seshia has received research support from DARPA. The institution of Prof. Seshia has received research support from University of California Noyce Program.
-
Dr. Lansberg has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Genentech. Dr. Lansberg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Lansberg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novo Nordisk. Dr. Lansberg has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Richard & Connor. Dr. Lansberg has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Fraser Watson Croutch. Dr. Lansberg has received publishing royalties from a publication relating to health care.